FDA
-
-
-
-
-
-
-
Artivion presents positive AMDS trial data at European cardiac surgery meeting
-
-
-
-
-
-
-
Canaccord Genuity Starts Artivion Inc. (AORT) at Buy
-
-
-
-
-
-
-
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting
-
-
-
-
-
-
-
Needham Reiterates Buy Rating on Artivion Inc. (AORT)
-
-
-
-
-
-
-
Artivion (AORT) Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial
-
-
-
-
-
-
-
Artivion Reports Third Quarter 2022 Financial Results
-
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

